Solstice Advanced Materials Inc. (SOLS) | The Buildout — AI Infrastructure

The Verdict

Solstice Advanced Materials makes specialty materials that sit inside other companies' products: low global warming potential refrigerants, uranium conversion services for nuclear power, sputtering targets and thermal materials for chipmaking, high-strength fibers, and high-barrier pharmaceutical packaging. For the AI buildout it is a supplier rather than a primary player — its targets and thermal materials go into leading-edge semiconductor nodes, and its refrigerants go into data-center cooling. Both links are embedded inside larger segments, and the company reports two of them: Refrigerants & Applied Solutions and Electronic & Specialty Materials.

Earnings

Solstice reported second-quarter 2026 net sales of $1.148 billion, up 11% year over year and above the top end of guidance. Gross margin was 32.2%, and adjusted EBITDA was $290 million at a 25.3% margin — also above the top end. GAAP net income attributable to Solstice was $119 million, or $0.75 per diluted share, with adjusted diluted EPS of $0.88. Management said six of seven businesses grew in the quarter, four of them at double-digit rates.

Management tone: The guidance posture shifted from holding to raising. On the first-quarter 2026 call management reaffirmed full-year 2026 guidance and said it would relook after the second quarter; on the second-quarter call it raised all four metrics. On electronics, the language moved from expansion to pull-forward, with capex pulled in because demand is strong. The explanation for RAS margin pressure moved from HFO mix and higher R&D to plant-turnaround timing and prior-year production-incentive credits. Nuclear commentary became more specific, citing three SMR supply agreements and contract discussions into the mid-2030s. Management said it is largely through the Honeywell transition services agreements. The topic management deflected was portfolio optimization, which the CEO called premature and which IR tied to spin-off guardrails.

Management Guidance

On July 30, 2026, management raised full-year 2026 guidance across all four metrics: net sales to $4.125–4.185B from $3.9–4.1B, adjusted EBITDA to $1.035–1.055B, adjusted diluted EPS to $2.75–2.95, and capex to $420–440M. For the third quarter it guided net sales of $990M–$1.03B with no explicit EBITDA range, directing analysts to a low-25% margin range instead. It reaffirmed RAS adjusted EBITDA margins in the mid-30% for the second half of 2026, and a nuclear product-loan return of about $30M of negative revenue in H2 2026, skewed modestly toward the fourth quarter. Corporate expense was framed as roughly $60M per quarter. After the Element termination, the company affirmed third-quarter and full-year 2026 guidance on August 27, 2026.

Trajectory

Revenue growth is accelerating. Q2 2026 net sales of $1.148B were up 11% year over year and up 15.8% from the $991M reported in Q1 2026. The margin picture is split. Company-level margin is roughly stable, with operating margin expanding 170 basis points and EBITDA margin expanding 150 basis points, only because a rising ESM margin offsets a falling RAS one. RAS adjusted EBITDA fell 6% year over year in Q2 2026 and its margin fell 648 basis points to 32.9%, which management attributed to plant-turnaround timing and prior-year production-incentive credits. ESM went the other way: adjusted EBITDA rose 24% year over year and margin expanded 280 basis points to 21.6%. Corporate drag is easing as the Honeywell transition services agreements roll off.

The Model

The model projects FY+1 revenue of $4,190M and EBITDA of $1,027M, a 24.5% margin, and FY+2 revenue of $4,660M and EBITDA of $1,202M, a 25.8% margin. The near-term anchor is the raised full-year 2026 guide and the H2 2026 capacity ramp at Spokane, alongside the RAS margin bridge. FY+2 depends on the electronics expansion flowing through, nuclear debottlenecking reaching full capacity in 2027, and the HFO mix shift toward roughly 70/30 exiting 2026 into 2027.

Projections are the median of 5 independent model runs. The model’s revenue sits 6.5% above analyst consensus.

On July 30, 2026, management raised full-year 2026 guidance across all four metrics: net sales to $4.125–4.185B from $3.9–4.1B, adjusted EBITDA to $1.035–1.055B, adjusted diluted EPS to $2.75–2.95, and capex to $420–440M. For the third quarter it guided net sales of $990M–$1.03B with no explicit EBITDA range, directing analysts to a low-25% margin range instead. It reaffirmed RAS adjusted EBITDA margins in the mid-30% for the second half of 2026, and a nuclear product-loan return of about $30M of negative revenue in H2 2026, skewed modestly toward the fourth quarter. Corporate expense was framed as roughly $60M per quarter. After the Element termination, the company affirmed third-quarter and full-year 2026 guidance on August 27, 2026.

What Could Go Right — and Wrong

Looking Ahead

Over the next twelve months the checkable items are operational. RAS adjusted EBITDA margin has to reach mid-30% in H2 2026 to validate the turnaround explanation, and Spokane has to show rising output as the expansion comes online. The nuclear story moves from narrative toward commitment if the expansion study concludes and longer-term contracts are signed. The nuclear product-loan return clears the way for FY2027 volumes at full capacity. The $500M buyback authorized on August 27, 2026 has no stated completion date.

Financials

Annual Summary

Key Ratios (Trailing)

The Company

Solstice Advanced Materials is a global advanced-materials company spun out of Honeywell in a tax-free spin-off completed October 30, 2025. It describes itself as a provider of refrigerants, blowing agents, conversion services for the nuclear energy sector, semiconductor materials, protective fibers and healthcare packaging. It reports two segments. Refrigerants & Applied Solutions (RAS) makes low global warming potential refrigerants, blowing agents, solvents and aerosol materials, plus conversion services for the nuclear energy sector. Electronic & Specialty Materials (ESM) makes electronic materials, high-strength fibers and laboratory life-science chemicals.

The company runs 20 manufacturing sites, with 16 in the Americas, 3 in Asia Pacific and 1 in EMEA, according to its 10-K, which gives no individual plant names or per-plant capacity. It is in its first year as a stand-alone public company and is still working through the separation. Transition services agreements with Honeywell were largely complete by the second quarter of 2026, and stand-alone public-company costs raised selling, general and administrative expense and interest expense above what the business carried inside Honeywell. Management counts seven businesses across the two reported segments.

Business Segments

Competitive Landscape

The competitive picture differs by business. In refrigerants, the 10-K names Arkema, Chemours, Daikin, Orbia and not-in-kind alternatives as the main RAS competitors — a field of large incumbents. In nuclear conversion, the company says it and joint-venture partner General Atomics are the only provider of uranium hexafluoride conversion services in the U.S., which its 10-K carries as the only sole-source disclosure in the structured risks output. In Electronic Materials, management calls copper manganese sputtering targets the go-to product for leading-edge nodes, and describes the business as capacity-constrained rather than demand-constrained.

Supply Chain

Solstice supplies specialty materials to chipmakers, nuclear utilities, and HVAC and pharma customers, and buys refrigerant feedstocks and transition services from Honeywell, its former parent. None of the neighboring company transcripts reviewed in the source material names Solstice or SOLS directly.